Why does Chronic Care get all the dog medicines?

Quote

anonymous

Guest
https://www.evaluate.com/vantage/articles/news/trial-results/mercks-cough-win-might-be-irrelevant

I Just don’t understand why Merck is dropping promotion on JANUVIA so they can do disease
Awareness on this Bullshit Chronic Cough drug. Click on this link or do research on your own,
60% side effect & 20% discontinue rate. Another when all else fails drug, and lets face it Verquvo
Is going nowhere fast. Who is signing off on these decisions?? What happen to new and innovative
Medicines from Research?
 




anonymous said:
https://www.evaluate.com/vantage/articles/news/trial-results/mercks-cough-win-might-be-irrelevant

I Just don’t understand why Merck is dropping promotion on JANUVIA so they can do disease
Awareness on this Bullshit Chronic Cough drug. Click on this link or do research on your own,
60% side effect & 20% discontinue rate. Another when all else fails drug, and lets face it Verquvo
Is going nowhere fast. Who is signing off on these decisions?? What happen to new and innovative
Medicines from Research?
Click to expand...
Drug was acquired, didn't even come from our R&D...
 












anonymous said:
https://www.evaluate.com/vantage/articles/news/trial-results/mercks-cough-win-might-be-irrelevant

I Just don’t understand why Merck is dropping promotion on JANUVIA so they can do disease
Awareness on this Bullshit Chronic Cough drug. Click on this link or do research on your own,
60% side effect & 20% discontinue rate. Another when all else fails drug, and lets face it Verquvo
Is going nowhere fast. Who is signing off on these decisions?? What happen to new and innovative
Medicines from Research?
Click to expand...

You Merckies complain about everything. If you get 1 script of Verquvo your manager showers you with gifts and praise. On the other hand Novartis reps selling Entresto are getting hammered by their managers because they are at 85% to plan. Let’s face it Merckies you guys are overpaid and underworked!!!!
 








anonymous said:
You Merckies complain about everything. If you get 1 script of Verquvo your manager showers you with gifts and praise. On the other hand Novartis reps selling Entresto are getting hammered by their managers because they are at 85% to plan. Let’s face it Merckies you guys are overpaid and underworked!!!!
Click to expand...


SPOT ON!!! We are super spoiled to be fair and I truly believe once you lose this life, you’ll look back and regret moaning about the easy life!!
 




Remembering this headline:

Merck shares hammered after FDA rejects Cordaptive!!

Early 2008 was the time, we actually had a launch meeting;
Entire divisions where chopped after this, I think group E and D.
Thousands of Reps where butchered!! I fear something similar if Chronic Cough doesn’t get approved in March.
 








anonymous said:
https://www.evaluate.com/vantage/articles/news/trial-results/mercks-cough-win-might-be-irrelevant

I Just don’t understand why Merck is dropping promotion on JANUVIA so they can do disease
Awareness on this Bullshit Chronic Cough drug. Click on this link or do research on your own,
60% side effect & 20% discontinue rate. Another when all else fails drug, and lets face it Verquvo
Is going nowhere fast. Who is signing off on these decisions?? What happen to new and innovative
Medicines from Research?
Click to expand...

Does it really matter? Chronic Care is dead anyway. We are specialty company, and you are lucky to still have a position calling on primary care. You must be new
 




anonymous said:
https://www.evaluate.com/vantage/articles/news/trial-results/mercks-cough-win-might-be-irrelevant

I Just don’t understand why Merck is dropping promotion on JANUVIA so they can do disease
Awareness on this Bullshit Chronic Cough drug. Click on this link or do research on your own,
60% side effect & 20% discontinue rate. Another when all else fails drug, and lets face it Verquvo
Is going nowhere fast. Who is signing off on these decisions?? What happen to new and innovative
Medicines from Research?
Click to expand...

Does it really matter? Chronic Care is dead anyway. We are specialty company, and you are lucky to still have a position calling on primary care. You must be new
 












anonymous said:
Remembering this headline:

Merck shares hammered after FDA rejects Cordaptive!!

Early 2008 was the time, we actually had a launch meeting;
Entire divisions where chopped after this, I think group E and D.
Thousands of Reps where butchered!! I fear something similar if Chronic Cough doesn’t get approved in March.
Click to expand...

A repeat of that will come soon. Is it true that they are exploiting reps over at chronic care? SMH Like the movie Get Out, I got out! Just in time.
 




anonymous said:
A repeat of that will come soon. Is it true that they are exploiting reps over at chronic care? SMH Like the movie Get Out, I got out! Just in time.
Click to expand...

that crazy movie sums up what is going on in chronic care. Sadly this division has a festering problem besides casual racism. Favoritism, bias, and misogyny is rampant in chronic care.
 




















Top Bottom
Back
Quote